Design and synthesis of substituted clubbed triazolyl thiazole as XDR and MDR antituberculosis agents Part-II | Abstract

Der Pharma Chemica
Journal for Medicinal Chemistry, Pharmaceutical Chemistry, Pharmaceutical Sciences and Computational Chemistry

ISSN: 0975-413X
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission Systemof respective journal.


Design and synthesis of substituted clubbed triazolyl thiazole as XDR & MDR antituberculosis agents Part-II

Author(s): Dinkar Mundhe, A. V. Chandewar, M. R. Shiradkar

Medicinal chemist are striving to arrive at a promising anti-tubercular agents which can be effective against XDR & MDR tuberculosis. This has made them to work non-conventionally to arrive at promising “Hit”. This article describes synthesis and antimycobacterial activity of clubbed thiazolyl-triazole molecule which are synthesised overriding the Lipinski rule of five. The compounds have shown potency comparable with isoniazid even with 25 XDR & MDR clinical isolates. The candidate is under further development status and is showing promising activity with minimal toxicity.


Select your language of interest to view the total content in your interested language

30+ Million Readerbase
SCImago Journal & Country Rank
Google Scholar citation report
Citations : 25868

Der Pharma Chemica received 25868 citations as per Google Scholar report

Der Pharma Chemica peer review process verified at publons
Der Pharma Chemica- Journals on pharmaceutical chemistry